A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/10 (2006.01) A61K 31/198 (2006.01) A61K 47/34 (2006.01) A61P 1/04 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2581076
The present invention provides pharmaceutical suspensions of D-methionine in which the aqueous solubility of D-methionine is exceeded, thereby allowing oral administration of higher doses. The present invention also provides processes for preparing these suspensions. The present invention further provides methods for preventing, treating, or ameliorating oral mucositis, hearing loss due to chemotherapy, antibiotics and noise, neuronal damage due to various CNS disorders and injuries, and anthracycline toxicity.
La présente invention concerne des suspensions pharmaceutiques de D-méthionine dans lesquelles la solubilité aqueuse de la D-méthionine est accrue, ce qui permet d'obtenir une administration par voie orale en plus fortes doses. Cette invention concerne également des procédés de préparation de ces suspensions. Cette invention concerne en outre des méthodes permettant de prévenir, de traiter, ou d'améliorer la mucosite orale, la perte auditive provoquée par la chimiothérapie, les antibiotiques et le bruit, les dommages neuronaux provoqués par divers troubles et blessures du système nerveux central, ainsi que la toxicité de l'anthracycline.
Mbm Intellectual Property Law Llp
Molecular Therapeutics Inc.
LandOfFree
D-methionine formulation with improved biopharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with D-methionine formulation with improved biopharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and D-methionine formulation with improved biopharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1939760